0: In conclusion, our results show that the fusion oncogene  RUNX1/RUNX1T1 controls alternative splicing in AML.
1: These findings add to the complexity in the organization of leukemia-driving transcriptomes and set a paradigm for the role of fusion gene-encoded transcription factors in RNA processing.
